{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:45:57Z","timestamp":1790509557405,"version":"4.1.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.3892\/mmr.2015.4494","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T08:35:25Z","timestamp":1446453325000},"page":"35-40","source":"Crossref","is-referenced-by-count":45,"title":["Role of histone deacetylase 3 in ankylosing spondylitis via negative feedback loop with microRNA-130a and enhancement of tumor necrosis factor-1\u03b1 expression in peripheral blood mononuclear cells"],"prefix":"10.3892","volume":"13","author":[{"given":"YA","family":"JIANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"key":"key20180108024613_b1-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1093\/nar\/gkt156","article-title":"IL-1\u03b2-specific recruitment of GCN5 histone acetyltransferase induces the release of PAF1 from chromatin for the de-repression of inflammatory response genes","volume":"41","author":"Kim","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"key20180108024613_b2-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar2489","article-title":"Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: Should we keep our HATs on?","volume":"10","author":"Grabiec","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"key20180108024613_b3-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.4049\/jimmunol.0903610","article-title":"Conditional deletion of histone deacetylase 1 in T cells leads to enhanced airway inflammation and increased Th2 cytokine production","volume":"185","author":"Grausenburger","year":"2010","journal-title":"J Immunol"},{"key":"key20180108024613_b4-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2010-05-284711","article-title":"Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection","volume":"117","author":"Roger","year":"2011","journal-title":"Blood"},{"key":"key20180108024613_b5-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1868-7083-5-11","article-title":"Transcription factor NFkB regulates the expression of the histone deacetylase SIRT1","volume":"5","author":"Katto","year":"2013","journal-title":"Clin Epigenetics"},{"key":"key20180108024613_b6-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1359-6446(04)03309-4","article-title":"Histone deacetylase inhibitors: New drugs for the treatment of inflammatory diseases?","volume":"10","author":"Blanchard","year":"2005","journal-title":"Drug Discov Today"},{"key":"key20180108024613_b7-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2222.2004.02006.x","article-title":"Trichostatin A attenuates airway inflammation in mouse asthma model","volume":"35","author":"Choi","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"key20180108024613_b8-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jbspin.2014.02.011","article-title":"CIC-1431: Biological treatments given in patients with rheumatoid arthritis or ankylosing spondylitis modify HAT\/HDAC (histone acetyl-transferase\/histone deacetylase) balance","volume":"81","author":"Toussirot","year":"2014","journal-title":"Joint Bone Spine"},{"key":"key20180108024613_b9-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.33382","article-title":"Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"64","author":"Gillespie","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20180108024613_b10-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar2500","article-title":"Epigenetic modifications in rheumatoid arthritis","volume":"10","author":"Strietholt","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"key20180108024613_b11-mmr-13-01-0035","doi-asserted-by":"crossref","DOI":"10.1007\/s00109-014-1192-8","article-title":"Denbinobin upregulates miR-146a expression and attenuates IL-1\u03b2-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes","author":"Yang","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"key20180108024613_b12-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cei.12374","article-title":"Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production","volume":"177","author":"Lu","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"key20180108024613_b13-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humimm.2009.11.008","article-title":"miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis","volume":"71","author":"Fulci","year":"2010","journal-title":"Hum Immunol"},{"key":"key20180108024613_b14-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar2493","article-title":"Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"10","author":"Pauley","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"key20180108024613_b15-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/nm.2815","article-title":"The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-\u03b1","volume":"18","author":"Zhu","year":"2012","journal-title":"Nat Med"},{"key":"key20180108024613_b16-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cei.12089","article-title":"Aberrant expression of microRNAs in T cells from patients with ankylosing spondylitis contributes to the immunopathogenesis","volume":"173","author":"Lai","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"key20180108024613_b17-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"e68611","DOI":"10.1371\/journal.pone.0068611","article-title":"Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3","volume":"8","author":"Meng","year":"2013","journal-title":"PloS One"},{"key":"key20180108024613_b18-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jvh.12131","article-title":"MicroRNA-130a inhibits HCV replication by restoring the innate immune response","volume":"21","author":"Li","year":"2014","journal-title":"J Viral Hepat"},{"key":"key20180108024613_b19-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2014.04.024","article-title":"Downregulation of connexin43 by microRNA-130a in cardiomyocytes results in cardiac arrhythmias","volume":"74","author":"Osbourne","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"key20180108024613_b20-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"e6161","DOI":"10.1371\/journal.pone.0006161","article-title":"Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a","volume":"4","author":"Kim","year":"2009","journal-title":"PloS One"},{"key":"key20180108024613_b21-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1038\/onc.2011.470","article-title":"Myc represses miR-15a\/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas","volume":"31","author":"Zhang","year":"2012","journal-title":"Oncogene"},{"key":"key20180108024613_b22-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"28019","DOI":"10.1074\/jbc.M114.578229","article-title":"miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs","volume":"289","author":"Kim","year":"2014","journal-title":"J Biol Chem"},{"key":"key20180108024613_b23-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(02)00468-9","article-title":"The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2","volume":"9","author":"Zhang","year":"2002","journal-title":"Mol Cell"},{"key":"key20180108024613_b24-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1158\/1541-7786.MCR-08-0548","article-title":"NF-kappaB activation, dependent on acetylation\/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells","volume":"7","author":"Bendinelli","year":"2009","journal-title":"Mol Cancer Res"},{"key":"key20180108024613_b25-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.4049\/jimmunol.173.6.3979","article-title":"Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression","volume":"173","author":"Mahlknecht","year":"2004","journal-title":"J Immunol"},{"key":"key20180108024613_b26-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"e105416","DOI":"10.1371\/journal.pone.0105416","article-title":"Histone deacetylase 3 Promotes RCAN1 Stability and nuclear translocation","volume":"9","author":"Han","year":"2014","journal-title":"PloS One"},{"key":"key20180108024613_b27-mmr-13-01-0035","first-page":"862969","volume":"2014","author":"Fabbroni","year":"2014","journal-title":"Drug retention rates and treatment discontinuation among anti-TNF-\u03b1 agents in psoriatic arthritis and ankylosing spondylitis in clinical practice"},{"key":"key20180108024613_b28-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jcpt.12045","article-title":"Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis","volume":"38","author":"Fenix-Caballero","year":"2013","journal-title":"J Clin Pharm Ther"},{"key":"key20180108024613_b29-mmr-13-01-0035","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10067-013-2369-1","article-title":"Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients","volume":"33","author":"Costa","year":"2014","journal-title":"Clin Rheumatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.4494\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:57:26Z","timestamp":1718168246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.4494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,2]]},"published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.3892\/mmr.2015.4494"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.4494","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,2]]}}}